NYS Entity Status
NYS Filing Date
SEPTEMBER 02, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2014 - BRONFMAN ASSOCIATES III LLC
AROUND THE WEB
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
- Excerpts From The Times’s Interview With Trump
By THE NEW YORK TIMES - Thursday Jul 20, 2017
President Trump discussed a range of issues, including the Russia investigation, with three New York Times reporters in the Oval Office.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Lawmaker seeks probe after AP reveals maggots in NY facility
By DAVID KLEPPER, Associated Press - Saturday Aug 12, 2017
ALBANY, N.Y. (AP) — A New York state lawmaker is demanding a federal investigation into New York state's care for the disabled following a recent Associated Press story that revealed the case of a man infested with maggots in a state-run group home.Democratic Assemblyman Anthony Brindisi, of Utica, told the AP on Saturday that he is asking the U.S. Department of Health and Human Services to investigate the group home and other state-regulated facilities for the disabled where there have been allegations of abuse and neglect.A copy of the report was obtained by The Associated Press, which found that New York state is not alone in making it difficult for members of the public to access records about allegations of abuse and neglect in state-regulated facilities for the disabled.
- A New Drug for Chorea?
Saturday Aug 12, 2017
A new drug called Austedo, has been approved by the FDA for the treatment of involuntary movements associated with chorea. Austedo is a small molecule drug designed to regulate neuronal levels of dopamine and was successful in suppression of movements associated with chorea in Phase III clinical trials. However, the drug does offer unwanted side -